Christopher Paul Ruffini, MD in Neward, DE - Medicare Gastroenterology

Christopher Paul Ruffini, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Neward, Delaware. He went to Jefferson Medical College Of Thomas Jefferson University and graduated in 1988 and has 36 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice Christiana Care Health Services Inc, Delaware Center For Digestive Care Llc and his current practice location is 537 Stanton Christiana Rd, Mid Atlantic Gi Consultants Suite 203, Neward, Delaware. You can reach out to his office (for appointments etc.) via phone at (302) 225-2380.

Christopher Paul Ruffini is licensed to practice in Delaware (license number C10004361) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1770590424.

Contact Information

	Christopher Paul Ruffini, MD
	537 Stanton Christiana Rd, Mid Atlantic Gi Consultants Suite 203, Neward, DE 19713
	(302) 225-2380
	(302) 225-2388

Physician's Profile

Full Name	Christopher Paul Ruffini
Gender	Male
Speciality	Gastroenterology
Experience	36 Years
Location	537 Stanton Christiana Rd, Neward, Delaware
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Christopher Paul Ruffini attended and graduated from Jefferson Medical College Of Thomas Jefferson University in 1988

NPI Data:

NPI Number: 1770590424
Provider Enumeration Date: 08/02/2006
Last Update Date: 06/17/2011

Medicare PECOS Information:

PECOS PAC ID: 8820997042
Enrollment ID: I20110113000572

Medical Identifiers

Medical identifiers for Christopher Paul Ruffini such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770590424	NPI	-	NPPES
0000611201	Medicaid	DE
4533424	Other		AETNA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	C10004361 (Delaware)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Christiana Hospital	Newark, DE	Hospital
St Francis Hospital	Wilmington, DE	Hospital
Union Hospital Of Cecil County	Elkton, MD	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Christiana Care Health Services Inc	9739097569	1248
Delaware Center For Digestive Care Llc	5890089353	54

News Archive

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.

Study reveals autism prevalence may be higher than current estimates in Korean children

Autism may be more common worldwide than previously thought, according to researchers from the George Washington University and Yale University.

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Experts say that by understanding how a person responds to specific nutrients, healthcare practitioners could provide better nutritional advice.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Christopher Paul Ruffini allows following entities to bill medicare on his behalf.

Entity Name	Christiana Care Health Services Inc
Entity Type	Part B Supplier - Hospital Department(s)
Entity Identifiers	NPI Number: 1487083069 PECOS PAC ID: 9739097569 Enrollment ID: O20140428000026

News Archive

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Autism may be more common worldwide than previously thought, according to researchers from the George Washington University and Yale University.

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Experts say that by understanding how a person responds to specific nutrients, healthcare practitioners could provide better nutritional advice.

Entity Name	Delaware Center For Digestive Care Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1558722561 PECOS PAC ID: 5890089353 Enrollment ID: O20160805000253

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Autism may be more common worldwide than previously thought, according to researchers from the George Washington University and Yale University.

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Experts say that by understanding how a person responds to specific nutrients, healthcare practitioners could provide better nutritional advice.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher Paul Ruffini is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Christopher Paul Ruffini, MD 537 Stanton Christiana Rd, Mid Atlantic Gi Consultants Suite 203, Neward, DE 19713 Ph: (302) 225-2380	Christopher Paul Ruffini, MD 537 Stanton Christiana Rd, Mid Atlantic Gi Consultants Suite 203, Neward, DE 19713 Ph: (302) 225-2380

News Archive

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Autism may be more common worldwide than previously thought, according to researchers from the George Washington University and Yale University.

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Experts say that by understanding how a person responds to specific nutrients, healthcare practitioners could provide better nutritional advice.

Christopher Paul Ruffini, MD - Medicare Gastroenterology in Neward, DE

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Medicare Reassignments

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market

Study reveals autism prevalence may be higher than current estimates in Korean children

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Internal Medicine Doctors in Neward, DE